Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 17/20 | 0.55 |
| ▸ | KDM6B | O15054 | 7/20 | 0.55 |
| ▸ | KDM4D | Q6B0I6 | 4/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | KDM4A | O75164 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | THRB | P10828 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27713383 | 0.79 | CCNC (0.42) | KDM4CKDM6BKDM4DKDM4ETDP1 | |
| SCHEMBL27619957 | 0.79 | KDM4C (0.42) | KDM4CKDM6BKDM4DKDM4ETDP1 | |
| SCHEMBL5014069 | 0.78 | KDM4C (0.49) | KDM4CKDM6BKDM4DKDM4ETDP1 | |
| SCHEMBL20976802 | 0.77 | KDM4C (0.45) | KDM4CKDM6BKDM4DKDM4ETDP1 | |
| SCHEMBL17746099 | 0.76 | KDM4C (0.47) | KDM4CKDM6BKDM4DKDM4ETDP1 | |
| SCHEMBL71335 | 0.76 | KDM4C (0.65) | KDM4CKDM6BKDM4DKDM4ETDP1 | |
| SCHEMBL29416303 | 0.76 | KDM4C (0.65) | KDM4CKDM6BKDM4DKDM4ETDP1 | |
| Hydrochloric Acid SCHEMBL10697489 | 0.74 | KDM4C (0.63) | KDM4CKDM6BKDM4DKDM4ETDP1 | |
| SCHEMBL28799175 | 0.74 | KDM4C (0.63) | KDM4CKDM6BKDM4DKDM4ETDP1 | |
| SCHEMBL19857493 | 0.74 | KDM4C (0.63) | KDM4CKDM6BKDM4DKDM4ETDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110190267-A1 | PRODRUGS OF OPIOIDS AND USES THEREOF | SHIRE PHARMACEUTICALS, INC. (US) | 2011-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110190267-A1 | PRODRUGS OF OPIOIDS AND USES THEREOF | OPRK1, OPRL1, OPRM1 | KDM4C 1602/4885KDM6B 1289/4885KDM4D 1933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.